PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
53.51%
Some net income increase while MRVL is negative at -2425.26%. John Neff would see a short-term edge over the struggling competitor.
37.00%
D&A growth well above MRVL's 31.88%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
716.37%
Deferred tax of 716.37% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
495026.74%
SBC growth of 495026.74% while MRVL is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-132.48%
Both reduce yoy usage, with MRVL at -286.85%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
266.15%
Some inventory rise while MRVL is negative at -705.77%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
-150.01%
Both reduce yoy usage, with MRVL at -232.24%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
100.35%
Well above MRVL's 141.99%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-20.37%
Both yoy CFO lines are negative, with MRVL at -106.96%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-162.95%
Both yoy lines negative, with MRVL at -15.41%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-3043200.00%
Both yoy lines negative, with MRVL at -81531.87%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-108.63%
Negative yoy purchasing while MRVL stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
53.13%
We have some liquidation growth while MRVL is negative at -98.53%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
-10342.61%
Both yoy lines negative, with MRVL at -283.94%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
27.55%
Lower share issuance yoy vs. MRVL's 341.84%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.